NASDAQ:INNV InnovAge (INNV) Stock Price, News & Analysis $5.97 -0.20 (-3.24%) (As of 10/17/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About InnovAge Stock (NASDAQ:INNV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InnovAge alerts:Sign Up Key Stats Today's Range$5.81▼$6.1550-Day Range$5.34▼$6.3652-Week Range$3.52▼$6.61Volume21,381 shsAverage Volume38,030 shsMarket Capitalization$811.85 millionP/E RatioN/ADividend YieldN/APrice Target$6.50Consensus RatingHold Company OverviewInnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Read More… [Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. InnovAge Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks10th Percentile Overall ScoreINNV MarketRank™: InnovAge scored higher than 10% of companies evaluated by MarketBeat, and ranked 972nd out of 1,012 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingInnovAge has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageInnovAge has only been the subject of 1 research reports in the past 90 days.Read more about InnovAge's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for InnovAge are expected to grow in the coming year, from ($0.01) to $0.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -37.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -37.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 2.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about InnovAge's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.49% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in InnovAge has recently increased by 1.62%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.49% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in InnovAge has recently increased by 1.62%, indicating that investor sentiment is decreasing. News and Social Media2.5 / 5News Sentiment0.58 News SentimentInnovAge has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for InnovAge this week, compared to 1 article on an average week.MarketBeat Follows1 people have added InnovAge to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $26,013.00 in company stock.Percentage Held by InsidersOnly 0.41% of the stock of InnovAge is held by insiders.Percentage Held by InstitutionsOnly 12.26% of the stock of InnovAge is held by institutions.Read more about InnovAge's insider trading history. Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address INNV Stock News HeadlinesInnovAge Holding Corp. (NASDAQ:INNV) Insider Sells $26,013.40 in StockSeptember 19, 2024 | insidertrades.comInnovAge (NASDAQ:INNV) Coverage Initiated at KeyCorpOctober 13, 2024 | americanbankingnews.com[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.October 17, 2024 | Paradigm Press (Ad)Keybanc Initiates Coverage of InnovAge Holding (INNV) with Sector Weight RecommendationOctober 12, 2024 | msn.comInnovAge Provides Update on Clinical & Operational Transformations at National PACE Association Annual ConferenceOctober 11, 2024 | globenewswire.comGrabar Law Office Investigates Claims on Behalf of Shareholders of InnovAge Holding Corp (INNV) as Class Action Survives Motion to DismissSeptember 24, 2024 | stockhouse.comUPDATE – Leading PACE Provider InnovAge Selected to Participate in National Study Focused on Preventing Falls by SeniorsSeptember 16, 2024 | globenewswire.comLeading PACE Provider InnovAge Selected to Participate in National Study Focused on Preventing Falls by SeniorsSeptember 16, 2024 | globenewswire.comSee More Headlines INNV Stock Analysis - Frequently Asked Questions How have INNV shares performed this year? InnovAge's stock was trading at $6.00 at the start of the year. Since then, INNV shares have decreased by 0.5% and is now trading at $5.97. View the best growth stocks for 2024 here. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (NASDAQ:INNV) released its quarterly earnings results on Tuesday, September, 10th. The company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The company earned $199.40 million during the quarter, compared to analysts' expectations of $190.19 million. InnovAge had a negative net margin of 2.79% and a negative trailing twelve-month return on equity of 7.43%. When did InnovAge IPO? InnovAge (INNV) raised $301 million in an IPO on Thursday, March 4th 2021. The company issued 16,700,000 shares at a price of $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers. How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Netflix (NFLX) and Home Depot (HD). Company Calendar Last Earnings9/10/2024Today10/17/2024Next Earnings (Estimated)11/05/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:INNV CUSIPN/A CIK1834376 Webwww.innovage.com Phone844-803-8745FaxN/AEmployees2,350Year FoundedN/APrice Target and Rating Average Stock Price Target$6.50 High Stock Price Target$7.00 Low Stock Price Target$6.00 Potential Upside/Downside+8.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-21,340,000.00 Net Margins-2.79% Pretax Margin-2.86% Return on Equity-7.43% Return on Assets-3.96% Debt Debt-to-Equity Ratio0.27 Current Ratio1.25 Quick Ratio1.25 Sales & Book Value Annual Sales$763.86 million Price / Sales1.06 Cash FlowN/A Price / Cash FlowN/A Book Value$2.04 per share Price / Book2.93Miscellaneous Outstanding Shares135,988,000Free Float135,065,000Market Cap$811.85 million OptionableOptionable Beta0.39 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report This page (NASDAQ:INNV) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.